The World's Greatest Investing Community
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This stock is poised to go higher given NBS' strategic position within the stem cell industry, their cash flow from cell storage off setting cash burn, the number and stage of clinical trials as well as longer term trending in the cell industry as a whole.